Study of Oglemilast for the Treatment of Asthma

NCT00322686 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Oglemilast
DRUG: Placebo then Oglemilast

Sponsor

Forest Laboratories